Reciprocal coordination of a combination oral contraceptive containing desogestrel+ethinyl estradiol on the expression of LOX-1 and LDLR in placental trophoblast cells

Contraception

Volumn 84, Issue 6, 2011, Pages

  Pandey, Hemlata ^a   Arjuman, Albina ^a   Roy, Kallol K ^a   Chandra, Nimai Chand ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Desogestrel; Ethinyl estradiol; LDL receptor; LOX 1; Oral combination contraceptive

Indexed keywords

DESOGESTREL; ETHINYLESTRADIOL; LOW DENSITY LIPOPROTEIN RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1;

ARTICLE; ATHEROSCLEROSIS; CELL ISOLATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; ORAL CONTRACEPTION; PLACENTA; PROTEIN EXPRESSION; TERM BIRTH; TROPHOBLAST;

ATHEROSCLEROSIS; CELL LINE; CELLS, CULTURED; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, HORMONAL; CONTRACEPTIVES, ORAL, SYNTHETIC; DESOGESTREL; DOWN-REGULATION; ETHINYL ESTRADIOL; FEMALE; HUMANS; HYPOLIPIDEMIC AGENTS; PREGNANCY PROTEINS; RECEPTORS, LDL; SCAVENGER RECEPTORS, CLASS E; TROPHOBLASTS; UP-REGULATION;

EID: 81155152485     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2011.05.017     Document Type: Article

References (41)

1. L. Shufelt, and N.B. Merz Contraceptive hormone use and cardiovascular disease J Am Coll Cardio 53 2009 221 231
2. R.L. Barbieri, L. Speroff, and A.M. Walker Therapeutic controversy: the safety of third generation oral contraceptives J Clin Endocr Metab 84 1999 1822 1829 (Pubitemid 30646992)
3. N.R. Poulter, C.L. Chang, and T.M.M. Farley Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study Lancet 346 1995 1575 1582 (Pubitemid 26001838)
4. T.M.M. Farley, O. Meirik, and C.L. Chang Effect of different progestogens in low oestrogen oral contraceptives on venous thromboembolic disease Lancet 346 1995 1582 1588 (Pubitemid 26001839)
5. K.W.M. Bloemenkamp, F.M. Hehnerhorst, and F.R. Rosendaal Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen Lancet 346 1995 1593 1596 (Pubitemid 26001841)
6. D. Carnell, H. Karcher, and L.G. Lie Third generation oral contraceptives - the controversy BMJ 311 1995 1589 1590
7. H. Jeon, and S.C. Blacklow Structure and physiologic function of the low-density lipoprotein receptor Annu Rev Biochem 74 2005 535 562 (Pubitemid 40995517)
8. M.S. Brown, and J.L. Goldstein Receptor-mediated control of cholesterol metabolism Science 191 1976 150 154
9. J.L. Witztum The oxidation hypothesis of atherosclerosis Lancet 344 1994 793 795 (Pubitemid 24283962)
10. P. Wahl, C. Walden, and R. Knopp Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol N Engl J Med 308 1983 862 867 (Pubitemid 13116538)
11. T. Foulon, N. Payen, and F. Laporte Effect of two low-dose oral contraceptives containing ethinylestradiol and either desogestrel or levonorgestrel on serum lipids and lipoproteins with particular regard to LDL size Contraception 64 2001 11 16 (Pubitemid 32787091)
12. J. Endrikat, C. Klipping, and C. Gerlinger A double-blind comparative study of the effects of a 23-day oral contraceptive regimen with 20 μg ethinyl estradiol and 75 μg gestodene and a 21-day regimen with 30 μg ethinyl estradiol and 75 μg gestodene on hemostatic variables, lipids and carbohydrate metabolism Contraception 64 2001 235 241 (Pubitemid 34020818)
13. J. Barkfeldt, A. Virkkunen, and T. Dieben The effects of two progestogen-only pills containing either desogestrel (75 μg/day) or levonorgestrel (30 μg/day) on lipid metabolism Contraception 64 2001 295 299 (Pubitemid 34075556)
14. R. Jurcut, A. Florian, and D. Deleanu Atherothrombosis in 2 vascular territories in a young woman: importance of thrombophilia testing Clin Appl Thromb Hemost 17 2011 108 113
15. F. Dentali, M. Crowther, and W. Ageno Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis Blood 107 2006 2766 2773
16. F.R. Rosendaal, F.M. Helmerhorst, and J.P. Vandenbroucke Female hormones and thrombosis Arterioscler Thromb Vasc Biol 22 2002 201 210 (Pubitemid 34127028)
17. I. Martinelli, E. Sacchi, and G. Landi High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives N Engl J Med 338 1998 1793 1797 (Pubitemid 28277959)
18. R. Mango, F. Clementi, and P. Borgiani Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction J Med Genet 40 2003 933 936 (Pubitemid 38117545)
19. M.C. Kowala, R. Kowala, and S. Beyer Characterization of atherosclerosis in LDL receptor knockout mice: macrophage accumulation correlates with rapid and sustained expression of aortic MCP-1/JE Atherosclerosis 149 2000 323 330 (Pubitemid 30145542)
20. N.R. Melo, M.C. Latrilha, and R.D. Santos Effects in post-menopausal women of transdermal estrogen associated with progestin upon the removal from the plasma of a microemulsion that resembles low-density lipoprotein (LDL) Maturitas 50 2005 275 281 (Pubitemid 40365030)
21. G. Ramakrishnan, A. Rana, and C. Das Study of low-density lipoprotein receptor regulation by oral (steroid) contraceptives: desogestrel, levonorgestrel and ethinyl estradiol in JEG-3 cell line and placental tissue Contraception 76 2007 297 305 (Pubitemid 47444291)
22. A. Arjuman, H. Pandey, and N.C. Chandra Effect of a combination oral contraceptive (desogestrel+ethinyl estradiol) on the expression of low-density lipoprotein receptor and its transcription factor (SREBP2) in placental trophoblast cells Contraception 84 2011 160 168
23. T. Kita LOX-1, a possible clue to the missing link between hypertension and atherogenesis Circ Res 84 1999 1113 1115 (Pubitemid 29227691)
24. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248 254
25. Royal College of General Practitioners' Oral Contraceptive Study Mortality among oral contraceptive users Lancet 2 1977 727 731
26. B.V. Stadel Oral contraceptives and cardiovascular disease N Engl J Med 305 1981 612 618 [First of two parts]
27. B.V. Stadel Oral contraceptives and cardiovascular disease N Engl J Med 305 1981 672 677 [Second of two parts] (Pubitemid 11056136)
28. J.E. Dalen, and R.B. Hickler Oral contraceptives and cardiovascular disease Am Heart J 101 1981 626 639 (Pubitemid 11120528)
29. T.W. Meade, G. Greenberg, and S.G. Thompson Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-μg preparations Br Med J 280 1980 1157 1161 (Pubitemid 10116200)
30. W.H.W. Inman, M.P. Vessey, and B. Westerholm Thromboembolic disease and the steroidal content of oral contraceptives: a report to the Committee on Safety of Drugs Br Med J 2 1970 303 309
31. J.L. Goldstein, and M.S. Brown Lipoprotein receptors and the control of plasma LDL cholesterol levels Eur Heart J 13 Suppl B 1992 34 36
32. M.S. Brown, and J.L. Goldstein The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor Cell 89 1997 331 340 (Pubitemid 27220877)
33. T. Sawamura, N. Kume, and T. Aoyama An endothelial receptor for oxidized low-density lipoprotein Nature 386 1997 73 77 (Pubitemid 27130922)
34. H. Moriwaki, N. Kume, and H. Kataoka Expression of lectin-like oxidized low density lipoprotein receptor-1 in human and murine macrophages: upregulated expression by TNF-alpha FEBS Lett 440 1998 29 32 (Pubitemid 28558728)
35. G. Draude, N. Hrboticky, and R.L. Lorenz The expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) on human vascular smooth muscle cells and monocytes and its down-regulation by lovastatin Biochem Pharmacol 57 1999 383 386 (Pubitemid 29065286)
36. H. Yoshida, N. Kondratenko, and S. Green Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor Biochem J 334 1998 9 13 (Pubitemid 28420964)
37. R. Dominaitiene, S. Lindgren, and S. Janciauskiene Effects of differently oxidized LDL on the expression of pro-inflammatory molecules in human monocytes in vitro Toxicology 14 2001 83 97 (Pubitemid 32867898)
38. Y.S. Bae, J.H. Lee, and S.H. Choi Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2 Circ Res 104 2009 210 218
39. K. Ando, and T. Fujita Role of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in the development of hypertensive organ damage Clin Exp Nephrol 8 2004 178 182 (Pubitemid 39421365)
40. S. Nishimura, M. Akagi, and K. Yoshida Oxidized low-density lipoprotein (ox-LDL) binding to lectin-like ox-LDL receptor-1 (LOX-1) in cultured bovine articular chondrocytes increases production of intracellular reactive oxygen species (ROS) resulting in the activation of NF-kappaB Osteoarthritis Cartilage 12 2004 568 576 (Pubitemid 38950267)
41. T. Hunt, R. Geetha, and E. Warga The bioavailability of desogestrel/ethinyl estradiol tablets relative to the oral solution Clin Drug Invest 15 1998 507 514 (Pubitemid 28288635)